Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Interventional × Prostatic Diseases × Clear all

Phase

Status

Sponsor Class

OTHER 26 INDUSTRY 20 NETWORK 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 213 Carcinoma, Non-Small-Cell Lung 147 Lung Neoplasms 128 Lymphoma 119 Prostatic Neoplasms 113 Leukemia 102 Ovarian Neoplasms 100 Central Nervous System Neoplasms 95 Precursor Cell Lymphoblastic Leukemia-Lymphoma 89 Colorectal Neoplasms 89 Head and Neck Neoplasms 86 Sarcoma 84 Multiple Myeloma 80 Squamous Cell Carcinoma of Head and Neck 73 Rectal Neoplasms 62 Leukemia, Myeloid, Acute 61 Carcinoma, Ovarian Epithelial 61 Uterine Cervical Neoplasms 60 Neoplasm Metastasis 59 Brain Neoplasms 57 Colonic Neoplasms 56 Fallopian Tube Neoplasms 53 Astrocytoma 53 Lymphoma, Large B-Cell, Diffuse 50 Glioblastoma 49 Burkitt Lymphoma 47 Urinary Bladder Neoplasms 46 Neuroblastoma 44 Melanoma 44 Hodgkin Disease 44

Interventions

talazoparib 1 enzalutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06582628 2024-12-02

TEAM PC

Fundacion Oncosur

Phase 2 Recruiting

Prostatic Diseases, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡